Lack of timely testing and adequate treatment during pregnancy contributed to majority of cases of congenital syphilis
MONDAY, Nov. 13, 2023 (HealthDay News) — In 2022, there were 3,761 cases of congenital syphilis, including 231 still births and 51 infant deaths, with lack of timely testing and adequate treatment during pregnancy contributing to most cases, according to a Vital Signs report published in the Nov. 7 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Robert McDonald, M.D., from the CDC in Atlanta, and colleagues used a cascading framework to identify and classify missed opportunities to prevent congenital syphilis among cases reported to the CDC in 2022. The authors reviewed data on testing and treatment during pregnancy and clinical manifestations present in the newborn to further identify missed opportunities to prevent congenital syphilis.
The researchers identified 3,761 cases of congenital syphilis that were reported to the CDC in 2022, including 231 and 51 still births and infant deaths (6 and 1 percent, respectively). In 88 percent of cases of congenital syphilis, lack of timely testing and adequate treatment during pregnancy contributed. Across all races, ethnicities, and U.S. Census Bureau regions, testing and treatment gaps were present in the majority of cases.
“Congenital syphilis rates are rapidly increasing in the United States and are at the highest level in at least 30 years,” the authors write. “Addressing patient and system-level barriers to accessing testing, treatment, and care could help prevent congenital syphilis.”
One Dose of Benzathine Penicillin G Noninferior to Three Doses for Syphilis
USPSTF Continues to Recommend Syphilis Screening Early in Pregnancy
USPSTF Recommends Early Screening for Syphilis in Pregnancy
Opt-Out Syphilis Screening in ED Improves Screening, Diagnosis
NEWS2 Scores Can ID Patients With Suspected Sepsis Needing Timely Treatment
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors
Genomic Newborn Screening Could ID Cancer Predisposition Syndrome